[{"address1": "201 Brookline Avenue", "address2": "Suite 901", "city": "Boston", "state": "MA", "zip": "02215", "country": "United States", "phone": "857 320 4900", "website": "https://www.tangotx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company develops TNG462, an oral small molecule methylthioadenosine-cooperative inhibitor for the treatment for cancers with methylthioadenosine phosphorylase deletions; TNG260, a co-repressor of repressor element-1 silencing transcription -selective inhibitor; TNG348, an ubiquitin-specific protease 1 inhibitor to treat patients with BRCA1 or BRCA2-mutant cancers; and Target 3 for STK11-mutant cancers. It has a strategic collaboration with Gilead Sciences, Inc. for the discovery, development, and commercialization of a pipeline of therapies for patients with cancer. Tango Therapeutics, Inc. was founded in 2017 and is headquartered in Boston, Massachusetts.", "fullTimeEmployees": 140, "companyOfficers": [{"maxAge": 1, "name": "Dr. Barbara L. Weber M.D.", "age": 67, "title": "President, CEO & Director", "yearBorn": 1957, "fiscalYear": 2023, "totalPay": 1039811, "exercisedValue": 0, "unexercisedValue": 9991192}, {"maxAge": 1, "name": "Dr. Adam S. Crystal M.D., Ph.D.", "age": 47, "title": "President of Research & Development", "yearBorn": 1977, "fiscalYear": 2023, "totalPay": 977216, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Alan  Ashworth FRS, Ph.D.", "age": 62, "title": "Founder & Member of Scientific Advisory Board", "yearBorn": 1962, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. William G. Kaelin Jr., M.D.", "age": 66, "title": "Founder & Member of Scientific Advisory Board", "yearBorn": 1958, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Antoni  Ribas M.D., Ph.D.", "age": 56, "title": "Founder & Member of Scientific Advisory Board", "yearBorn": 1968, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Timothy  Redfern", "age": 45, "title": "Chief Financial Officer", "yearBorn": 1979, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael  Palmieri Ph.D.", "title": "Head of Technical Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jannik N. Andersen Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Douglas J. Barry Esq., J.D.", "age": 54, "title": "Chief Legal Officer, Chief Compliance Officer & Corporate Secretary", "yearBorn": 1970, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Julie  Carretero", "age": 52, "title": "Chief Human Resources Officer", "yearBorn": 1972, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 4, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1738368000, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.43, "open": 2.45, "dayLow": 2.35, "dayHigh": 2.5, "regularMarketPreviousClose": 2.43, "regularMarketOpen": 2.45, "regularMarketDayLow": 2.35, "regularMarketDayHigh": 2.5, "payoutRatio": 0.0, "beta": 0.805, "forwardPE": -1.6619718, "volume": 541521, "regularMarketVolume": 530989, "averageVolume": 988652, "averageVolume10days": 633350, "averageDailyVolume10Day": 633350, "bid": 2.33, "ask": 2.38, "bidSize": 10, "askSize": 3, "marketCap": 253506464, "fiftyTwoWeekLow": 2.35, "fiftyTwoWeekHigh": 12.015, "priceToSalesTrailing12Months": 5.8434515, "fiftyDayAverage": 2.9654, "twoHundredDayAverage": 6.551675, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 5373297, "profitMargins": -2.84432, "floatShares": 45955491, "sharesOutstanding": 107418000, "sharesShort": 5441461, "sharesShortPriorMonth": 7493267, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.0507, "heldPercentInsiders": 0.08456001, "heldPercentInstitutions": 1.00323, "shortRatio": 6.88, "shortPercentOfFloat": 0.0933, "impliedSharesOutstanding": 107418000, "bookValue": 2.134, "priceToBook": 1.1059043, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -123395000, "trailingEps": -1.15, "forwardEps": -1.42, "enterpriseToRevenue": 0.124, "enterpriseToEbitda": -0.039, "52WeekChange": -0.78869563, "SandP52WeekChange": 0.2021538, "quoteType": "EQUITY", "currentPrice": 2.36, "targetHighPrice": 16.0, "targetLowPrice": 8.0, "targetMeanPrice": 11.5, "targetMedianPrice": 11.5, "recommendationMean": 1.33333, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 8, "totalCash": 293278016, "totalCashPerShare": 2.73, "ebitda": -137202000, "totalDebt": 37626000, "quickRatio": 7.803, "currentRatio": 8.004, "totalRevenue": 43383000, "debtToEquity": 16.418, "revenuePerShare": 0.402, "returnOnAssets": -0.2237, "returnOnEquity": -0.48794997, "grossProfits": -97937000, "freeCashflow": -62539248, "operatingCashflow": -122321000, "revenueGrowth": 0.082, "grossMargins": -2.2575, "ebitdaMargins": 0.0, "operatingMargins": -2.8326, "financialCurrency": "USD", "symbol": "TNGX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "exchange": "NGM", "messageBoardId": "finmb_424111353", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "marketState": "POST", "corporateActions": [], "regularMarketChangePercent": -2.8806655, "regularMarketPrice": 2.36, "shortName": "Tango Therapeutics, Inc.", "longName": "Tango Therapeutics, Inc.", "postMarketTime": 1740171904, "regularMarketTime": 1740171600, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1599139800000, "postMarketChangePercent": 0.0, "postMarketPrice": 2.36, "postMarketChange": 0.0, "regularMarketChange": -0.07000017, "regularMarketDayRange": "2.35 - 2.5", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 988652, "fiftyTwoWeekLowChange": 0.00999999, "fiftyTwoWeekLowChangePercent": 0.0042553153, "fiftyTwoWeekRange": "2.35 - 12.015", "fiftyTwoWeekHighChange": -9.655001, "fiftyTwoWeekHighChangePercent": -0.8035789, "fiftyTwoWeekChangePercent": -78.86956, "earningsTimestampStart": 1742214600, "earningsTimestampEnd": 1742560200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.15, "epsForward": -1.42, "epsCurrentYear": -1.20544, "priceEpsCurrentYear": -1.9577912, "fiftyDayAverageChange": -0.6054001, "fiftyDayAverageChangePercent": -0.20415461, "twoHundredDayAverageChange": -4.191675, "twoHundredDayAverageChangePercent": -0.63978684, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "displayName": "Tango Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-02-21"}]